230 related articles for article (PubMed ID: 37569430)
1. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569430
[TBL] [Abstract][Full Text] [Related]
2. Urinary Oxidative Stress Biomarker Levels Might Be Useful in Identifying Functional Bladder Disorders in Women with Frequency and Urgency Syndrome.
Jiang YH; Jhang JF; Kuo HC
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983336
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Hsu YH; Kuo HC
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms.
Yu WR; Chang WC; Kuo HC
Int Urol Nephrol; 2022 Sep; 54(9):2157-2165. PubMed ID: 35804206
[TBL] [Abstract][Full Text] [Related]
5. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
Jiang YH; Jhang JF; Kuo HC
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252
[TBL] [Abstract][Full Text] [Related]
6. Videourodynamic characteristics of interstitial cystitis/bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology.
Kuo YC; Kuo HC
Neurourol Urodyn; 2018 Aug; 37(6):1971-1977. PubMed ID: 29504632
[TBL] [Abstract][Full Text] [Related]
7. Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Ho HC; Chiou DY; Kuo HC
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885006
[TBL] [Abstract][Full Text] [Related]
8. Discriminating Different Bladder and Bladder Outlet Dysfunctions by Urinary Biomarkers in Women with Frequency-Urgency Syndrome.
Jhang JF; Jiang YH; Kuo HC
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979652
[TBL] [Abstract][Full Text] [Related]
9. Role of Bladder Dysfunction in Men with Lower Urinary Tract Symptoms Refractory to Alpha-blocker Therapy: A Video-urodynamic Analysis.
Jiang YH; Liao CH; Kuo HC
Low Urin Tract Symptoms; 2018 Jan; 10(1):32-37. PubMed ID: 27366877
[TBL] [Abstract][Full Text] [Related]
10. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
11. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625885
[TBL] [Abstract][Full Text] [Related]
12. Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction.
Ackerman AL; Jackson NJ; Caron AT; Kaufman MR; Routh JC; Lowder JL
medRxiv; 2023 Apr; ():. PubMed ID: 37131628
[TBL] [Abstract][Full Text] [Related]
13. Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunction.
Jiang YH; Chen SF; Kuo HC
Ci Ji Yi Xue Za Zhi; 2020; 32(2):121-130. PubMed ID: 32269943
[TBL] [Abstract][Full Text] [Related]
14. Combination of urinary biomarkers and machine-learning models provided a higher predictive accuracy to predict long-term treatment outcomes of patients with interstitial cystitis/bladder pain syndrome.
Jhang JF; Yu WR; Huang WT; Kuo HC
World J Urol; 2024 Mar; 42(1):173. PubMed ID: 38507059
[TBL] [Abstract][Full Text] [Related]
15. Alteration of Urothelial Inflammation, Apoptosis, and Junction Protein in Patients with Various Bladder Conditions and Storage Bladder Symptoms Suggest Common Pathway Involved in Underlying Pathophysiology.
Liu HT; Jiang YH; Kuo HC
Low Urin Tract Symptoms; 2015 May; 7(2):102-7. PubMed ID: 26663690
[TBL] [Abstract][Full Text] [Related]
16. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
Liu HT; Tyagi P; Chancellor MB; Kuo HC
BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
[TBL] [Abstract][Full Text] [Related]
17. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
Jiang YH; Wang CC; Kuo HC
PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
[TBL] [Abstract][Full Text] [Related]
18. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):914. PubMed ID: 33441752
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis.
Jiang YH; Jhang JF; Kuo HC
PLoS One; 2016; 11(3):e0151692. PubMed ID: 26999787
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of the Maximum Urethral Closing Pressure in Women With Overactive Bladder Symptoms and Functional Bladder Outlet Obstruction.
Kim SJ; Choo HJ; Yoon H
Int Neurourol J; 2022 Feb; 26(Suppl 1):S1-7. PubMed ID: 35236047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
